Alliances

Building bridges across science, industry, and society to bring new therapies closer to patients.

Innopharma’s ultimate goal is to drive drug discovery forward, both within the national and international landscape. From identifying unmet medical needs to industrial co-development, we achieve this by collaborating with public and private partners, actively participating in programs that promote drug discovery, and creating our own initiatives to foster innovation.

Discover about the partners, networks, and initiatives we are involved in.

Self-developed and co-developed organizations

Kaertor Foundation

Kaertor Foundation

The Kærtor Foundation is a global initiative pioneering open innovation and public-private co-development in drug discovery. It gives continuity to the results of the Innopharma project at USC and is led by Professors Mabel Loza, specialist in Pharmacology, and Ángel Carracedo, specialist in Genomic Medicine.

Consortiums

Industry partners

Academic partners

Network and clursters

European programs

National and regional organisms

Regional institutes

Beyond our main partners, we collaborate with many other institutions and companies through diverse projects.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.